SC
Squadron Capital Management LLC cut its MTRI stake below 5%
Squadron Capital Management LLC reported owning 0% of InMed Pharmaceuticals Inc. (MTRI) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G